Nautilus Biotechnology, Inc.

2.36 USD
-0.09 (-3.67%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Nautilus Biotechnology, Inc. stock is down -12.27% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 3 June’s closed higher than May. 0% of analysts rate it a buy.

About Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company was founded in 2016 and is headquartered in Seattle, Washington.